Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-05

Clinical Trial Update: Aripiprazole in the Treatment of Tourette's Syndrome [NA]

View source ↗

Summary

A clinical trial evaluating aripiprazole for Tourette's syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: University of Florida | Conditions: Tourette's Syndrome | NA | Status: TERMINATED